These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Hypertension strategies in the third millennium: conservatism, evidence and the folly of speculation. McIntyre HF Int J Clin Pract; 2009 Jan; 63(1):7-14. PubMed ID: 19125987 [No Abstract] [Full Text] [Related]
67. [Combination therapy of beta blockers for heart failure]. Watanabe M; Hirata Y Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376 [No Abstract] [Full Text] [Related]
68. [Therapy for hypertension associated with heart failure]. Miyamoto H; Imaizumi T Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730 [No Abstract] [Full Text] [Related]
69. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future. Piechowski-Jóźwiak B; Bogousslavsky J Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057 [TBL] [Abstract][Full Text] [Related]
71. Hypertension in an urban population--who is treated with what and how well? Li C; Hedblad B; Berglund G; Janzon L J Hum Hypertens; 2007 Apr; 21(4):323-6. PubMed ID: 17273156 [No Abstract] [Full Text] [Related]
72. [Evidence-based usefulness of Ca antagonists and ACEIs and ARBs for the primary and secondary prevention of major cardiovascular and renal events in patients with hypertension]. Fujino T; Hasebe N; Kikuchi K Clin Calcium; 2005 Oct; 15(10):1695-708. PubMed ID: 16199917 [TBL] [Abstract][Full Text] [Related]
73. [Do antihypertensive agents change the incidence of cardiovascular complications of hypertension?]. Himbert D; Paillole C; Dahan M; Steg PG; Laperche T; Gourgon R Ann Cardiol Angeiol (Paris); 1991 Dec; 40(10):607-12. PubMed ID: 1685878 [TBL] [Abstract][Full Text] [Related]
74. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies]. Katayama S Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740 [No Abstract] [Full Text] [Related]
75. [Primary prevention of stroke]. Uchiyama S; Nakamura T; Terashi H No To Shinkei; 2004 Nov; 56(11):907-19. PubMed ID: 15678947 [No Abstract] [Full Text] [Related]
76. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key. Bath P Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833 [No Abstract] [Full Text] [Related]
77. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. Strauss MH; Weinstein J; Newton GE N Engl J Med; 2009 Mar; 360(11):1148; author reply 1149-50. PubMed ID: 19283888 [No Abstract] [Full Text] [Related]
78. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2? Nicholls MG J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907 [No Abstract] [Full Text] [Related]
79. Summaries for patients. Effect of antihypertensive drugs on risk for atrial fibrillation. Ann Intern Med; 2010 Jan; 152(2):I-16. PubMed ID: 20083810 [No Abstract] [Full Text] [Related]
80. Which drug for treatment of hypertension? Cutler J Lancet; 1999 Feb; 353(9153):604-5. PubMed ID: 10030320 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]